Proteomic analysis allows for early detection of potential markers of metabolic impairment in very young obese children
暂无分享,去创建一个
J. Argente | J. Kopchick | V. Barrios | L. Sackmann-Sala | G. Martos-Moreno | S. Okada | Darlene E Berrymann
[1] J. Argente,et al. El proteoma del tejido adiposo subcutáneo muestra heterogeneidad anatómica , 2013 .
[2] E. Diamanti-Kandarakis,et al. Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome. , 2013, European journal of endocrinology.
[3] P. Codoñer-Franch,et al. Vitamin D status is linked to biomarkers of oxidative stress, inflammation, and endothelial activation in obese children. , 2012, The Journal of pediatrics.
[4] J. Argente,et al. Serum visfatin and vaspin levels in prepubertal children: effect of obesity and weight loss after behavior modifications on their secretion and relationship with glucose metabolism , 2011, International Journal of Obesity.
[5] J. Kopchick,et al. Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjects , 2011, Proteomics.
[6] J. Kopchick,et al. Identification of new biomarkers of low-dose GH replacement therapy in GH-deficient patients. , 2011, The Journal of clinical endocrinology and metabolism.
[7] J. Argente,et al. Effect of Weight Loss on High‐Molecular Weight Adiponectin in Obese Children , 2010, Obesity.
[8] W. Paulus,et al. Intravenous clusterin administration reduces myocardial infarct size in rats , 2010, European journal of clinical investigation.
[9] C. Bouchard,et al. Predicting adult body mass index-specific metabolic risk from childhood. , 2010, Metabolic syndrome and related disorders.
[10] L. Frohman,et al. Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[11] A. Pfeiffer,et al. Factors that influence retinol-binding protein 4-transthyretin interaction are not altered in overweight subjects and overweight subjects with type 2 diabetes mellitus. , 2009, Metabolism: clinical and experimental.
[12] J. Kopchick,et al. Perspective: proteomic approach to detect biomarkers of human growth hormone. , 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.
[13] N. Mikhail. The metabolic syndrome: Insulin resistance , 2009, Current hypertension reports.
[14] Florian Kronenberg,et al. Genetic-epidemiological evidence on genes associated with HDL cholesterol levels: A systematic in-depth review , 2009, Experimental Gerontology.
[15] V. Mericq,et al. Insulin Resistance Markers in Children , 2009, Hormone Research in Paediatrics.
[16] I. Quaye. Haptoglobin, inflammation and disease. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[17] L. Beilin,et al. CHILDHOOD OBESITY, HYPERTENSION, THE METABOLIC SYNDROME AND ADULT CARDIOVASCULAR DISEASE , 2008, Clinical and experimental pharmacology & physiology.
[18] H. Tilg,et al. Inflammatory Mechanisms in the Regulation of Insulin Resistance , 2008, Molecular medicine.
[19] T. Egashira,et al. Serum apolipoprotein j in health, coronary heart disease and type 2 diabetes mellitus. , 2006, Journal of atherosclerosis and thrombosis.
[20] M. Wolzt,et al. The Adipokine Visfatin is Markedly Elevated in Obese Children , 2006, Journal of pediatric gastroenterology and nutrition.
[21] C. Visser,et al. Clusterin: a protective mediator for ischemic cardiomyocytes? , 2005, American journal of physiology. Heart and circulatory physiology.
[22] A. Levy,et al. In Vivo and In Vitro Studies Establishing Haptoglobin as a Major Susceptibility Gene for Diabetic Vascular Disease , 2005, Vascular health and risk management.
[23] I. Trougakos,et al. Serum levels of the senescence biomarker clusterin/apolipoprotein J increase significantly in diabetes type II and during development of coronary heart disease or at myocardial infarction , 2002, Experimental Gerontology.
[24] J. Fruchart,et al. High-density lipoprotein subclasses and apolipoprotein A-I. , 1999, Clinica chimica acta; international journal of clinical chemistry.
[25] K. Saku,et al. Different effects of subclasses of HDL containing apoA-I but not apoA-II (LpA-I) on cholesterol esterification in plasma and net cholesterol efflux from foam cells. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[26] J. Fruchart,et al. Apolipoprotein A-containing lipoprotein particles: physiological role, quantification, and clinical significance. , 1992, Clinical chemistry.
[27] W. Friedrichs,et al. Extrahepatic expression of plasma protein genes during inflammation , 1991, Inflammation.
[28] K J Rothman,et al. No Adjustments Are Needed for Multiple Comparisons , 1990, Epidemiology.
[29] P. McNamara,et al. Serum protein binding and the role of increased alpha 1-acid glycoprotein in moderately obese male subjects. , 1984, British journal of clinical pharmacology.
[30] J. Argente,et al. Adipokines in childhood obesity. , 2013, Vitamins and hormones.
[31] G. Chiocchia,et al. Clusterin : A Multifacet Protein at the Crossroad of Inflammation and Autoimmunity , 2009 .